SCHEMBL447245

SCHEMBL447245

CC1CCCCCCCCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.43
KMT2A Q03164 1/20 0.43
EPHX1 P07099 1/20 0.42
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA4 P22748 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
GAA P10253 1/20 0.38
PKM P14618 1/20 0.38
ALDH1A1 P00352 2/20 0.36
POLB P06746 1/20 0.36
HSD17B10 Q99714 1/20 0.35
CA12 O43570 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
CYP2C19 P33261 1/20 0.33
SHBG P04278 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3675505 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2
Cyclohexane SCHEMBL3670822 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2
SCHEMBL14026664 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2
SCHEMBL802 1.00
SCHEMBL5189 1.00
SCHEMBL9256078 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2
Cycloheptane SCHEMBL23885013 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2
SCHEMBL7912061 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2
SCHEMBL15121491 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2
SCHEMBL9791506 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 629 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116848094-A Tertiary amine lipid compounds and uses thereof 华南理工大学 2023-10-03 CN claimed
WO-2023125184-A1 TERTIARY AMINE LIPID COMPOUND AND USE THEREOF 华南理工大学 2023-07-06 WO claimed
CN-110382010-A Bismuth-gadolinium nano particle 布里格姆妇女医院 2019-10-25 CN claimed
CN-110366432-A Tumour and immunocyte imaging based on PD-L1 expression 约翰霍普金斯大学 2019-10-22 CN claimed
CN-108555012-A A kind of processing heavy metal pollution of soil object band rotation drying system 徐州工程学院 2018-09-21 CN claimed
EP-2662434-B1 Use of specific compounds for enhancing odours SYMRISE AG (DE) 2018-03-21 EP claimed
EP-0193065-B1 Morpholine derivatives, processes for their production and their use as fungicides BASF AG (DE) 1995-08-23 EP claimed
EP-0048376-A1 Process for the preparation of N-substituted diaryl imidodicarboxylates BAYER AG (DE) 1982-03-31 EP claimed
US-20260035353-A1 PHENOL DERIVATIVES FOR USE AS ANTIMICROBIAL, ANTIBACTERIAL, BACTERICIDE SPECIAL PRODUCTS LINE S P A (IT) 2026-02-05 US disclosed
US-20240425639-A1 SEMI-AROMATIC POLYESTER, AND PREPARATION METHOD THEREFOR AND USE THEREOF JIANGSU KINGFA SCI & TECH. ADVANCED MATERIALS CO., LTD. (CN) 2024-12-26 US disclosed
US-20240229243-A1 NON-CR PASSIVATING COMPOSITION AND ARTICLE TREATED BY THE SAME CHEMETALL GMBH (DE) 2024-07-11 US disclosed
US-20240181494-A1 AQUEOUS COMPOSITION FOR METALLIC SURFACE TREATMENT AND THE APPLICATION THEREOF Shanghai Chemetall Chemicals Co., Ltd. (CN) 2024-06-06 US disclosed
EP-4347723-A1 NON-CR PASSIVATING COMPOSITION AND ARTICLE TREATED BY THE SAME Chemetall GmbH (DE) 2024-04-10 EP disclosed
EP-4337730-A1 AQUEOUS COMPOSITION FOR METALLIC SURFACE TREATMENT AND THE APPLICATION THEREOF Chemetall GmbH (DE) 2024-03-20 EP disclosed
US-4052435-A CROSSLINKING AGENTS STUDIENGESELLSCHAFT KOHLE M.B.H. (DT) 1977-10-04 US disclosed
US-4032585-A CROSSLINKING AGENTS STUDIENGESELLSCHAFT KOHLE M.B.H. (DT) 1977-06-28 US disclosed
US-3987097-A INCREASING AFFINITY FOR ANIONIC DYES SANDOZ LTD. (CH) 1976-10-19 US disclosed
US-3970545-A Hydrocarbon desulfurization utilizing a non-catalytic hydrogen donor step and an oxidation step ATLANTIC RICHFIELD COMPANY (US) 1976-07-20 US disclosed
US-3960897-A PEROXIDE RESEARCH CORPORATION (US) 1976-06-01 US disclosed
US-3936479-A 2-BENZAMIDO-BENZOPHENONES, UV STABILIZERS, PLASTICS SANDOZ LTD., (SANDOZ AG) (CH) 1976-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035353-A1 PHENOL DERIVATIVES FOR USE AS ANTIMICROBIAL, ANTIBACTERIAL, BACTERICIDE TLR7, GANC, ARG1 ACHE 2624/4885KMT2A 4794/4885EPHX1 3733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.